Tokai University   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Tokyo Japan (1946)

Organization Overview

First Clinical Trial
1999
NCT00133302
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Divison of Nephrology and Metabolism, Tokai University School of Medicine | Tokai University School of Medicine

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiovascular Diseases (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Hyperphosphatemia (Phase 2)

Hypertension (Phase 4)

Kidney Diseases (Phase 4)

Lymphoma (Phase 3)

Lymphoma, Non-Hodgkin (Phase 3)

Psoriasis (Phase 3)

Renal Insufficiency, Chronic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 11